magNews
Extra-VAD
-
CorporateMoyoAssist® Extra-VAD® Introduces Fully Magnetically Levitated Extracorporeal Heart Support Technology in China 2024-06-28
-
CorporateMoyoAssist® Launched! The Mid-to-Short-Term MCS Forum and Extra-VAD Clinical Technology Transformation Results Conference Successfully Held 2024-06-24
-
CorporateMoyoAssist® Extra-VAD, a Promising Solution for Short-to-Medium-Term Ventricular Assist for China NMPA trial, Showcased at 4th Academic Annual Conference of CSBE 2023-06-17
-
CorporateThe Chinese Start-Up Advancing Life Support Tech 2023-03-30
-
CorporatemagAssist Revealed in MedTech Outlook's Top 10 MedTech Companies in APAC Region for 2022 2023-03-14
-
Medical UpdatesThe FIRST transseptal cannulation treatment via MoyoAssist Extra-VAD 2022-08-24
-
TechnologymagAssist participation in the 9th World Congress of Biomechanics 2022 2022-07-10
-
Corporate2021 BlackBOX Melbourne X magAssist: A Collision between Design and Innovation 2021-12-28
-
Medical UpdatesProfessor Ping Li "Extra-VAD, could be a greater life-support solution for Bridging to Heart Transplantation" 2021-07-30
-
Medical UpdatesThe "Extra-VAD" jointly developed by Wuhan Union Medical College and magAssist Inc. was put into clinical use 2021-07-21
- Technology
- Patent
- Fluid Dynamics
- Full Magnetic Levitated Rotor
- Mechatronics
- Product Manufacturing
- Artificial Hearts
WeChat
Copyright © 2022-2025 magAssist Co., Ltd. All Rights Reserved
